JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aspinwall, C. A.
Right arrow Articles by Lakey, J. R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aspinwall, C. A.
Right arrow Articles by Lakey, J. R. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 50, Issue of December 12, 1997 pp. 31308-31314

Effects of Intravesicular H+ and Extracellular H+ and Zn2+ on Insulin Secretion in Pancreatic Beta Cells*

(Received for publication, August 6, 1997, and in revised form, October 3, 1997)

Craig A. Aspinwall Dagger , Sunday A. Brooks Dagger , Robert T. Kennedy Dagger § and Jonathan R. T. Lakey par

From the Dagger  Department of Chemistry, University of Florida, Gainesville, Florida 32611-7200 and the  Comprehensive Tissue Center, Department of Surgery, University of Alberta, Edmonton, Alberta T6H 2R8, Canada

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

The effects of extracellular Zn2+ and pH and intravesicular pH on insulin and 5-hydroxytryptamine (5-HT) secretion from pancreatic beta cells were investigated. Insulin and 5-HT secretion from single cells was detected by amperometry as a series of current spikes corresponding to detection of multimolecular packets secreted by exocytosis. Spike width was used as a measure of the kinetics of clearance from the cell and the area of spikes as a measure of amount released. Changes in extracellular pH from 6.9 to 7.9 caused insulin spikes to become narrower with no change in area, whereas the same treatments had no effect on 5-HT secretion. Treatment of cells with Bafilomycin A1 or N-ethylmaleimide, both of which are expected to increase intravesicular pH by inhibiting V-type H+-ATPase, had no effect on 5-HT secretion but caused insulin spikes to become more narrow. These results indicate that exposure to high pH, whether intravesicular or extracellular, accelerates release of insulin during exocytosis without affecting the amount of insulin released. Increasing extracellular Zn2+ concentration from 0 to 25 µM increased the width and decreased the area of insulin spikes without affecting 5-HT secretion. Zn2+ effects were likely exerted through a common-ion effect on Zn2+-insulin dissociation. It was concluded that intravesicular storage conditions and extracellular ions can affect free insulin concentration in the vicinity of beta cells during secretion.


INTRODUCTION

Insulin, produced and stored in pancreatic beta cells, is released by exocytosis in response to external stimuli, such as elevated glucose concentration. A greater understanding of exocytosis in beta cells is of intense interest because of the possible role of defective insulin secretion in type II diabetes (1, 2). Secretion by exocytosis can be considered to occur in several steps including vesicle docking, vesicle priming, vesicle fusion, and finally extrusion or clearance of vesicular contents into the extracellular medium (3). In this study, we examined the postfusion clearance of insulin from beta cell secretory vesicles during exocytosis.

Clearance of insulin from secretory vesicles is intimately related to the storage of insulin within a vesicle. Insulin is generally believed to be stored inside secretory vesicles as a solid hexamer bound with two Zn2+ ions per hexamer (4-6). This understanding is supported by a broad spectrum of evidence. It is known that in the presence of Zn2+, insulin will form tetramers and hexamers that bind Zn2+ in an insulin:Zn2+ ratio of 4:1 and 6:2, respectively (5), and that vesicles contain Zn2+ in 1-1.5-fold excess of that necessary to form Zn2+-insulin hexamers (7). Zn2+-insulin hexamers are insoluble below pH 7 (5, 6, 8, 9), and beta cell secretory vesicles possess a V-type H+-ATPase that maintains the vesicle interior at or below pH 6 (10, 11). Electron micrographs and immunohistology also suggest the presence of solid insulin inside vesicles (12, 13). During exocytosis, secretory vesicles fuse with the plasma membrane, exposing the vesicular interior to the extracellular milieu, allowing release of stored insulin granules. It is apparent that insulin must dissolve to escape the vesicle. In addition, insulin must dissociate from Zn2+ because insulin monomer is the biologically active form (14, 15). Little is known about the mechanism or time scale of dissolution and dissociation, although one study has demonstrated that insulin is free from Zn2+ within 60 s of release (4). Additional investigation of this phenomenon has been hindered by the lack of methods for monitoring insulin secretion with sufficient temporal resolution to observe such effects.

Recently, amperometry with microelectrodes has been applied to the study of exocytosis at a variety of cell types, including adrenal chromaffin cells (16-19), PC12 cells (20), mast cells (21), neurons (22), and melanotrophs (23, 24). Secretion is detected as a series of current spikes that correspond to detection of concentration pulses generated by exocytosis. Analysis of current spikes can reveal subtle details about secretion. The area of current spikes (measured in coulombs) can be used to quantitate the moles of detected hormone (or transmitter) released per vesicle using Faraday's Law (19). The dynamics of vesicular release are reflected in the shape of the current spikes. Specifically, the width of spikes can be used as a measure of the rate of clearance from the vesicle because the width is determined by any slow kinetic step involved in clearing hormone from the vesicle and diffusional broadening of the secreted packet of molecules (25-28). Thus, the exquisite temporal resolution and sensitivity of amperometry for measuring actual secretory products has made it well suited for probing postfusion events in exocytosis (25-27, 29, 30).

We have extended amperometry to detection of insulin exocytosed from pancreatic beta cells (31, 32). For this application, a carbon-fiber electrode modified with ruthenium oxide/cyanoruthenate (Ru-O/CN-Ru), a catalyst that promotes oxidation of insulin, is used for detection. This method has allowed the first direct measurement of exocytosis of insulin from single beta cells with high temporal resolution (32). In using amperometry to study postfusion events in insulin release, we have found it useful to measure 5-HT1 release as a control. 5-HT can be "loaded" into beta cells by incubating the cells in medium containing both 5-HT and 5-hydroxytryptaphan. Substantial evidence now exists that demonstrates that 5-HT is loaded primarily into beta cell secretory vesicles and that 5-HT is co-secreted with insulin by exocytosis (34-36).2 5-HT can be detected at bare carbon electrodes and insulin can be detected only at Ru-O/CN-Ru-modified electrodes. Thus, it is possible to measure, in separate experiments, secretion of 5-HT from loaded cells and secretion of insulin from cells that have not been allowed to accumulate 5-HT.

In an initial study on postfusion clearance of insulin, we found that exposure to a pH gradient between the vesicle and the extracellular environment is required to achieve rapid release of free insulin from solid Zn2+-insulin granules (37). In the present study, we extended this investigation to a variety of extracellular pH values. In addition, we examined the effect of intravesicular pH and extracellular Zn2+ on insulin secretion. The study reveals strong effects of the extracellular and intravesicular environments on the rate and amount of free insulin released during exocytosis.


MATERIALS AND METHODS

Electrode Preparation and Testing

Carbon fiber microelectrodes were constructed as described previously (38, 39). Finished electrodes consisted of a 9 µm carbon fiber (P-55S, Amoco Performance Products) sealed with epoxy (Miller Stephenson, Danbury, CT) in the tip of a glass pipette. The total electrode diameter at the tip was ~30 µm, and the electrode was polished at a 30-45° angle using a pipette beveler (BV-10, Sutter Instruments). For detection of insulin, electrodes were chemically modified as described previously to produce a mixed valent Ru-O/CN-Ru film (32), whereas 5-HT detection was performed with bare carbon fiber microelectrodes (34).2 Tests of the electrode response to insulin and 5-HT were performed by positioning the tips of electrodes approximately 10 µm from micropipette tips (outer diameter, 30 µm) under a Krebs-Ringer buffer solution on the stage of a microscope. Solutions were pressure-ejected from the tips of the pipettes at 9 p.s.i. for 5 s while the amperometric current was recorded.

Data Collection and Analysis

Amperometry was performed using a battery to apply potential to a sodium-saturated calomel electrode. Currents were monitored at the working electrode using an AI-403 current amplifier and Cyberamp 320 signal conditioner (Axon Instruments, Foster City, CA). For detection of 5-HT, the potential at the working electrode was 0.65 V, whereas for detection of insulin, the potential was 0.85 V. All voltages are versus a sodium-saturated calomel electrode. When using the modified electrode, the potential was held at 0.40 V between recordings to improve electrode stability as described elsewhere (32). Data were low pass filtered at 300 Hz for insulin measurements and at 1000 Hz for 5-HT. These filter settings were found to not affect the peak widths relative to higher settings. Data were collected at a rate that was three to five times the filter frequency using a personal computer (Gateway 2000 P5-166) via a data acquisition board (DigiData 1200B, Axon Instruments). The area and half-width of current spikes were calculated using software provided by Prof. R. Mark Wightman (University of North Carolina). For data analysis, spikes were used only if the signal:noise ratio was greater than 10. All means are reported ± 1 S.E. Statistical differences between means were evaluated using a two-tailed Student's t test.

Isolation of Canine Islets and in Vitro Culture

Unless otherwise stated, all chemicals for islet and cell culture were obtained from Life Technologies. Pancreatic islets were isolated from mongrel dogs using controlled collagenase (Boehringer Mannheim) perfusion via the duct, automated dissociation, and discontinuous Euro-Ficoll purification using the COBE 2991 blood cell processor as described previously (40, 41). Following isolation, groups of islets were placed in modified CMRL 1066 tissue culture solution (G-100) containing 10% fetal calf serum, 25 mM HEPES, 100 units/ml penicillin, and 100 µg/ml streptomycin and shipped overnight. Upon arrival, islets were immediately dispersed into single cells using a previously described procedure (32). Cells were plated onto tissue culture dishes (Corning) and incubated at 37 °C in 5% CO2 in G-100, pH 7.4.

Accumulation of 5-Hydroxytryptamine into Beta Cells

For experiments requiring measurement of 5-HT secretion, dispersed beta cells were allowed to incubate in G-100 containing 0.5 mM 5-HT and 1 mM 5-hydroxytryptophan for 16 h at 37 °C in 5% CO2, pH 7.40 (37).2 Cells were used for secretion experiments immediately after loading.

Single Cell Experiments

Single cell measurements were performed similar to those described elsewhere (19, 23, 31). All amperometric experiments were performed on a Zeiss Axiovert 100 inverted microscope. Cells were bathed in Krebs-Ringer buffer, pH 7.4 containing 118 mM NaCl, 5.4 mM KCl, 2.4 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, 25 mM NaHCO3, 0.010 mM forskolin (42), and 3.0 mM D-glucose and maintained at 37 °C and 5% CO2 on the stage of the microscope by a microincubator (Medical Systems, Inc.). Buffer pH was adjusted by varying the bicarbonate concentration to achieve the desired pH after bubbling with 5% CO2. Extracellular Zn2+ concentration was adjusted by adding ZnCl2 to the desired concentration. Ionic strength was held constant for all solutions. When appropriate, cells were incubated in G-100 containing either 50 µM N-ethylmaleimide or 1 µM Bafilomycin A1 for 30 min. Amperometry was performed at isolated single cells by positioning the sensing tip of the microelectrode 1 µm from the cell using a micromanipulator (PCS-250, Burleigh Instruments). Stimulant solution (200 µM tolbutamide in bicarbonate buffer) was applied to individual cells by pressure ejection for 10 s from a micropipette positioned ~30 µm from the cell.

Simulation of Spike Shape

A random-walk model was used to simulate diffusion-limited current spikes obtained from exocytosis (43). In the model, the cell was considered a hemisphere with a radius of 5 µm, and the electrode was centered directly over the apex of the cell, with a 1.0-µm gap between the cell and the electrode. An exocytosis event was modeled as a point source of 50,000 molecules diffusing from a location on the cell surface to the electrode. Thus, exocytosis events originating at the base of the cell travel farther to the electrode than exocytosis events originating at the apex of the cell, where the distance to the electrode was minimized. Molecules encountering the electrode were counted as detected and were removed from the system. Molecules encountering the cell membrane or the insulating portions of the electrode were reflected back to their previous position. The simulation was ended when all molecules were detected or after 3000 steps had been made in the walk. Longer random walks did not affect the results. For the model, 5-HT and insulin were considered to have diffusion coefficients of 6.0 × 10-6 and 2.0 × 10-6 cm2/s, respectively (31).


RESULTS

Effect of Zn2+ on Insulin Detection

We have previously used the Ru-O/CN-Ru electrode to detect insulin and insulin secretion (31, 32). An issue that has not been addressed but that is important in the interpretation of these data is the effect of Zn2+ complex formation on insulin detection. Fig. 1 illustrates current recorded during injection of Krebs-Ringer buffer solutions that contained 30 µM insulin (A) or 30 µM insulin along with 15 µM Zn2+, which promotes the formation of Zn2+-insulin complexes (B). As the data show, addition of Zn2+ abolished the signal obtained from detection of insulin. The presence of Zn2+ did not affect the detection of other, non-Zn2+ binding compounds, such as 5-HT (Fig. 1, C and D). These results strongly suggest that the electrode detects free insulin and not insulin complexed with Zn2+.


Fig. 1. Amperometric detection of free and Zn2+-complexed insulin. Current traces are recordings of 30 µM insulin (A), 30 µM insulin with 15 µM zinc (B), 5 µM 5-hydroxytryptamine (C), and 5 µM 5-hydroxytryptamine with 15 µM zinc (D), all dissolved in Krebs-Ringer buffer, applied to a Ru-CN/Ru-O-modified microelectrode by pressure ejection as described under "Materials and Methods." Current scale shown in A also applies in B, and that shown in C also applies in D.

[View Larger Version of this Image (8K GIF file)]


Spike Width Analysis

Fig. 2 compares high resolution recordings of spikes resulting from detection of insulin and 5-HT. Several differences in spike shape were observed for detection of 5-HT and insulin. The most marked difference in shape of the spikes was that the average width at half-height of 5-HT spikes was 5.3 ± 0.4 ms, which is significantly lower (p < 0.0005) than the 30 ± 2.1 ms obtained for insulin spikes. As mentioned under "Introduction," the width at half-height of a current spike is a measure of the time required for detected material to extrude from a vesicle, diffuse to the electrode, and be detected. Thus, some of the difference in width could be attributed to the difference in diffusion coefficient for 5-HT and insulin. The random walk model, which predicts widths based solely on diffusion, indicates that the insulin spikes should be three times the width of 5-HT spikes, yet we observed a 6-fold difference. The model also predicts that the widest diffusion-limited spikes, which would occur for a release site that is the maximum possible distance from the electrode, should be 22 ms for 5-HT and 58 ms for insulin. Experimentally, we found that none of the 5-HT spikes were broader than this maximum value. In contrast, 45% of the insulin spikes were over the maximum diffusion-limited width. Taken together, these results indicate that release of 5-HT is indistinguishable from diffusion control and that a factor other than diffusion contributes to slowing down the kinetics of release of insulin.


Fig. 2. Comparison of isolated spike shapes for insulin and 5-HT detection. Spikes are due to detection of insulin (A), 5-HT with no prespike feature (B), and 5-HT with a prespike feature (foot) (C).

[View Larger Version of this Image (9K GIF file)]


Another difference in shape was that 14% of the 5-HT spikes had a small current increase or "foot" prior to the rapid increase to the spike apex, as shown in Fig. 2C. In contrast, such features were not observed on spikes due to detection of insulin at physiological pH. Prespike features like those seen for 5-HT detection have also been observed in the detection of catecholamine release from adrenal chromaffin cells (16, 25) and 5-HT release from mast cells (21). This shape has been attributed to leakage of material from a fusion pore that forms prior to complete opening of the vesicle (16, 21, 25). The lack of a foot for detection of insulin suggests that insulin does not leak from a fusion pore in quantities that are detectable.

Effects of Extracellular pH on Insulin Extrusion

To evaluate the effect of extracellular pH on exocytosis, single cell recordings of insulin secretion were made following tolbutamide stimulation when the extracellular pH was 6.40, 6.90, 7.05, 7.20, 7.40, and 7.90. Similar experiments were performed for detection of 5-HT secretion from loaded cells at pH 6.40, 7.10, and 7.40. Fig. 3 summarizes the spike widths and areas that were recorded in these different experiments. As mentioned under "Introduction," the area of isolated current spikes is considered a direct measure of the amount of product (insulin or 5-HT in this case) detected from a single vesicle (19). Spike area for insulin detection is not significantly changed by increasing extracellular pH above 6.9 (Fig. 3A); however, no spikes were detected at pH 6.4. In contrast, the width at half-height of spikes decreased with increasing pH for insulin detection. The constant area combined with decreasing width caused an increase in amplitude with increasing pH for insulin detection. In contrast, the area and width at half-height for 5-HT current spike detection was unaffected at any pH tested.


Fig. 3. Comparison of insulin and 5-HT secretory area and width at half-height at different extracellular pH values. A, mean spike area obtained versus extracellular pH for insulin and 5-HT; B, mean half-width of spikes obtained versus extracellular pH for insulin and 5-HT. The asterisk (*) indicates that the difference from pH 7.4 had a significance of p < 0.0005. For insulin detection, numbers of spikes (n) were 53, 84, 15, 50, and 80 for pH 6.90, 7.05, 7.20, 7.40, and 7.90, respectively. For 5-HT detection, numbers of spikes (n) were 130, 84, and 107 for pH 6.40, 7.10, and 7.40, respectively. In all cases, at least four different cells were used to collect the spikes used.

[View Larger Version of this Image (23K GIF file)]


Effects of Intravesicular pH on Insulin and 5-HT Extrusion

To investigate the effect of the vesicular proton pump and lowered vesicular pH on insulin and 5-HT secretion, the effect of Bafilomycin A1 and N-ethylmaleimide, compounds known to inhibit V-type H+-ATPase activity and raise vesicular pH to cytoplasmic pH (44, 45), on spike shapes was evaluated. Fig. 4 compares typical current traces recorded at untreated cells and cells incubated with 1 µM Bafilomycin A1 or 50 µM N-ethylmaleimide. As observed from an inspection of these plots, the number of spikes per stimulation, duration of secretory activity, and area of the spikes are not significantly different for any of these treatments.


Fig. 4. Current recordings obtained from detection of insulin following treatment with control (A), 1 µM Bafilomycin A1 (B), and 50 µM N-ethylmaleimide (C). Treatments performed as described under "Materials and Methods." Bars under current traces represent application of stimulant. Dips in the current traces are a result of nonfaradaic processes due to stimulation. Recordings are from different cells.

[View Larger Version of this Image (15K GIF file)]


Although overall secretory activity for insulin was unaffected by ATPase inhibition, insulin spike shape was affected as illustrated in Fig. 5, A-C, and summarized in Fig. 5D. The spike width was significantly decreased (p < 0.001) by treatment with both agents. Furthermore, after treatment with Bafilomycin A1, 10% of the detected spikes exhibited a foot, and after treatment with N-ethylmaleimide 18% of spikes had this feature. Spike samples shown in Fig. 5, B and C, are typical of those that had a foot. As stated above, no spikes obtained from untreated cells had such prespike features. In contrast, the spike width for 5-HT was unaffected (Fig. 5D), and there was no effect on the percentage of 5-HT spikes with feet.


Fig. 5. Comparison of isolated current spikes obtained from detection of insulin following treatment with control (A), 1 µM Bafilomycin A1 (B), and 50 µM N-ethylmaleimide (C). Spikes in B and C are examples that display a foot. D, comparison of spike half-widths for insulin and 5-HT spikes following treatment with V-type H+-ATPase blockers. The asterisk (*) indicates that half-width was different from control with a significance of p < 0.001. For insulin detection, numbers of spikes (n) were 49, 230, and 145 for no treatment, 50 µM N-ethylmaleimide, and 1 µM Bafilomycin A1, respectively. For 5-HT detection, n values were 132, 65, and 140 for no treatment, 50 µM N-ethylmaleimide, and 1 µM Bafilomycin A1, respectively. Spikes were obtained from at least six different cells for each experiment. Other conditions the same as in Fig. 4.

[View Larger Version of this Image (15K GIF file)]


Effects of Extracellular Zn2+ Concentration on Insulin and 5-HT Extrusion

In addition to the effects of pH, the effects of 0, 5, 15, and 25 µM extracellular Zn2+ on secretion measurements were examined. Fig. 6 illustrates typical secretion measurements of insulin and 5-HT under these different conditions. As extracellular Zn2+ concentration increased, the area of insulin spikes decreased while the half-width increased, as summarized in Fig. 7. These combined effects caused spike amplitudes to decrease and result in detection of smaller numbers of spikes as illustrated in Fig. 6. The smaller number of spikes is presumed to result from fewer spikes being above the noise level because of the decreased amplitudes. This effect is maximized at 25 µM Zn2+, at which no insulin spikes were detected (data not shown). In contrast, when measuring 5-HT release, the area and half-width of the spikes were not significantly different at any given Zn2+ concentration (see Figs. 6 and 7).


Fig. 6. Current recordings obtained from detection of insulin with 0 µM extracellular Zn2+ (A), insulin with 15 µM extracellular Zn2+ (B), 5-HT with 0 µM extracellular Zn2+ (C), and 5-HT with 15 µM extracellular Zn2+ (D). Bars under current traces represent application of stimulant. Recordings are from different cells. Scale represents 10 pA (A), 5 pA (B), and 20 pA (C and D). Traces A and B were digitally low pass filtered at 30 Hz for presentation purposes.

[View Larger Version of this Image (11K GIF file)]



Fig. 7. Comparison of insulin and 5-HT secretory area and width at half-height at different extracellular [Zn2+]. A, effect of extracellular [Zn2+] on mean spike area for insulin and 5-HT. The asterisk (*) indicates difference from 0 µM [Zn2+] at a significance of p < 0.10, and ** indicates difference at p < 0.02. B, effect of extracellular [Zn2+] on mean half-width of spikes for insulin and 5-HT. The asterisk (*) indicates difference from 0 µM [Zn2+] at a significance of p < 0.001, and ** indicates difference at p < 0.01. For detection of insulin, numbers of spikes (n) were 76, 68, and 22, whereas for detection of 5-HT, n values were 198, 75, and 70 for 0, 5, and 15 µM extracellular zinc, respectively. For all experiments, at least five different cells were used.

[View Larger Version of this Image (19K GIF file)]



DISCUSSION

Dynamics of Exocytosis Events

Although 5-HT is released simultaneously with insulin, it escapes from the vesicle at a significantly higher rate, as evidenced by the narrower spikes and the presence of feet, which suggest leakage out of vesicles during fusion pore formation. 5-HT release is indistinguishable from simple diffusion out of the vesicle, whereas insulin release is slower, suggesting that a factor other than diffusion controls postfusion release. These results may be explained by considering differences in storage of the two secretory products. Although the exact form that 5-HT is stored in the vesicles is unknown, it is reasonable to expect that it is stored in solution because 5-HT is highly soluble at the vesicular pH. In contrast, insulin is stored as a solid complex of Zn2+-insulin (4, 5, 12). In addition, the electrode only detects free insulin and not Zn2+-bound insulin, as illustrated in Fig. 1. Therefore, it seems likely from these considerations that the dissolution and dissociation of Zn2+-insulin complex controls the rate of insulin extrusion during exocytosis.

Effects of Extracellular and Intravesicular pH

In our initial work, we demonstrated that a change in extracellular pH from 7.4 to 6.4 could hinder insulin clearance to such an extent as to make it undetectable by amperometry while having no effect on 5-HT secretion (37). The data in Fig. 3, obtained over a wider pH range, show that decreasing extracellular pH from 7.9 to 6.9 increases the time required for insulin clearance (increasing spike width) but does not affect the amount of insulin released during an exocytosis event (no change in area). 5-HT secretion is unaffected in this pH range (Fig. 3), proving that this effect is specific to insulin extrusion and is not an effect on vesicular fusion. Further investigation has revealed that increasing vesicular pH with V-type H+-ATPase inhibitors, which is expected to change the storage conditions for insulin, causes insulin to be more rapidly extruded (as demonstrated by narrower spikes) and even leak out of fusion pores (as demonstrated by the presence of feet). This effect suggests that some dissolution of the insulin granule occurs inside the vesicle when the vesicular pH is raised. Therefore, under normal conditions, low pH inside the vesicle maintains insulin in a solid state that does not escape as readily during fusion pore formation or vesicle fusion. These results further emphasize the importance of the pH gradient between the vesicle and extracellular media in rapidly changing insulin from a solid, storage state to a dissolved, releasable form. These results also highlight the difference between postfusion release of other hormones and insulin. For example, in catecholamine release from adrenal chromaffin cells, increasing the pH has the effect of increasing the time course of postfusion extrusion (25). Furthermore, the effects of pH on catecholamine release are not nearly as dramatic as those observed here. These differences can be attributed to differences in storage of the compounds. In the case of catecholamine, release requires the unraveling of a protein gel rather than dissolution of a solid-state hormone (25).

Effect of Zn2+ on Insulin Extrusion

In addition to dissolving, the insulin-Zn2+ complex must ultimately dissociate after vesicle fusion because the active form of insulin is a monomer (14, 15). We have postulated that availability of extracellular Zn2+ may affect the release of free insulin from beta cells through a common-ion effect. Extracellular Zn2+ concentrations in the range of 5-25 µM markedly decreased area and increased width of insulin spikes without affecting 5-HT spikes. The lack of an effect on 5-HT detection demonstrates that the effect is specific to insulin extrusion and not to earlier steps in exocytosis. Unlike pH manipulations, extracellular Zn2+ not only increased the time course of release of free insulin, but also decreased the amount of free insulin detected from an exocytosis event. Decreases in amount of free insulin detected occurred even though half-widths of detected spikes suggest that a release event is occurring at a fast enough rate to yield a detectable spike. A possible explanation for this result is that after vesicle fusion, the Zn2+-insulin hexamer dissolves but does not dissociate because of the high extracellular Zn2+ concentration, allowing most of the insulin to escape from the detection area in the undetectable Zn2+-insulin complex form. Interestingly, the effects of Zn2+ on insulin secretion are similar to those observed for catecholamine secretion from adrenal chromaffin cells (46). Although Zn2+ decreased the quanta in both cases, the chemical mechanisms are different. Rather than a common ion effect on complex, the Zn2+ effect on catecholamine secretion was due to the ability of Zn2+ to cross-link the protein matrix in chromaffin cell vesicles and hinder the escape of the hormone (46).

The results presented here demonstrate that micromolar Zn2+ concentrations can affect free insulin concentration in the immediate vicinity of a beta cell during secretion. The possible physiological significance of the Zn2+ effect is not clear because the actual concentration of Zn2+ in the interstitial space of an islet is not known; however, Zn2+ concentration in serum is approximately 15-25 µM (47-50). It has previously been demonstrated that in vivo insulin is available as free monomer within a few seconds of entering the portal vein, presumably because the large dilution of insulin drives dissociation (4); therefore, it seems unlikely that extracellular Zn2+ could affect the endocrine function of free insulin.

Regulation of Insulin Extrusion during Exocytosis

Our observations show that free insulin concentrations in the vicinity of beta cells are affected by the intravesicular pH and extracellular pH and Zn2+ concentrations. These results have been interpreted as effects on the rate of dissolution and dissociation as Zn2+-insulin hexamers during exocytosis. This interpretation ignores the possible role of vesicle matrix proteins, such as chromagranin, in storing and extruding free insulin. In adrenal chromaffin cells and mast cells, glycoproteins, such as chromagranin, in the vesicle matrix have been shown to be critical in storing and then extruding the secretory products (51-54). These studies have shown that matrix proteins help release the secretory products in a pH-dependent mechanism that involves ion exchange and phase transition of the storage proteins (51-54). Chromagranin is found in the secretory vesicles of beta cells (55-57) and therefore could play a similar role in extruding insulin. Our data cannot exclude such a possibility; however, it seems unlikely, given the differences in storage of insulin in beta cells and histamine or catecholamines in the other cells types. First, insulin is stored as a solid (4, 5, 6) and therefore is not associated with the chromagranin. Second, histochemical evidence shows that chromagranin in beta cell secretory vesicles is concentrated in the halo region separate from insulin in the dense core (57). Finally, in beta cell vesicles, insulin and C-peptide make up 80% of the protein content, and membrane-bound proteins make up 10%, leaving just 10% of the total protein as matrix proteins (58). Such a distribution would seem to preclude a dominant role for chromagranin in storing and dispersing insulin, especially given the importance of Zn2+-insulin complex formation in storage.

This study has revealed some of the chemical events involved in driving postfusion release of insulin from beta cells. The effects of H+ and Zn2+ on insulin release that were observed are a natural manifestation of the complex mechanism of insulin synthesis and storage. The fact that the quanta of insulin release and the rate of insulin release can be altered also raises the possibility that insulin secretion can be regulated by the intravesicular and extracellular ionic environment. Such postfusion control of release has recently been proposed as a novel regulatory mechanism in a variety of cell types (52). Postfusion regulation of insulin release would seem to hold little relevance to the endocrine action of insulin given the large distance between the release site and the site of action. However, several lines of evidence support the notion of an autocrine and/or paracrine role for insulin within an islet. Specifically, insulin has been demonstrated to (a) bind to islet cells (59), (b) affect insulin secretion (61, 62), and (c) activate insulin receptors in beta cell lines (60, 33). Therefore, if the intravesicular or extracellular ionic environment does mediate postfusion regulation of insulin release, then its effects would likely be exerted at the level of autocrine or paracrine signaling of insulin.


FOOTNOTES

*   This research was supported in part by National Institutes of Health Grant RO1 DK46960-01 from the NIDDK and by the Juvenile Diabetes Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Received support as a Presidential Faculty Fellow and an Alfred P. Sloan Fellow. To whom correspondence should be addressed, at the Department of Chemistry, University of Florida, P. O. Box 117200, Gainesville, FL 32611-7200. Tel.: 352-392-9839; Fax: 352-392-4582; E-mail: rtkenn{at}chem.ufl.edu.
par    Supported by a postdoctoral fellowship from the Alberta Heritage Foundation for Medical Research.
1   The abbreviation used is: 5-HT, 5-hydroxytryptamine.
2   C. A. Aspinwall, S. A. Brooks, J. R. T. Lakey, and R. T. Kennedy, submitted for publication.

REFERENCES

  1. Unger, R. H. (1991) Science 251, 1200-1205 [Abstract/Free Full Text]
  2. Rajan, A. S., Aguilar-Bryan, L., Nelson, D. A., Yaney, G. C., Hsu, W. H., Kunze, D. L., and Boyd, A. E., III (1990) Diabetes Care 13, 340-363 [Abstract]
  3. Zimmerberg, J. (1987) Biosci. Rep. 7, 251-268 [CrossRef][Medline] [Order article via Infotrieve]
  4. Gold, G., and Grodsky, G. M. (1984) Experentia 40, 1105-1114 [CrossRef][Medline] [Order article via Infotrieve]
  5. Blundell, T., Dodson, G., Hodkin, D., and Mercola, D. (1972) Adv. Protein Chem. 26, 279-402
  6. Emdin, S. O., Dodson, G. G., Cutfield, J. M., and Cutfield, S. M. (1980) Diabetologia 19, 174-189 [CrossRef][Medline] [Order article via Infotrieve]
  7. Foster, M. C., Leapman, R. D., Li, M. X., and Atwater, I. (1993) Biophys. J. 64, 525-532 [Abstract/Free Full Text]
  8. Tanford, C., and Epstein, J. (1954) J. Am. Chem. Soc. 76, 2170-2176 [CrossRef]
  9. Epand, R. M., Stafford, A. R., Tyers, M., and Nieboer, E. (1985) Mol. Pharmacol. 27, 366-374 [Abstract]
  10. Orci, L., Ravazzola, M., Amherdt, M., Madsen, O., Perrelet, A., Vassalli, J.-D., and Anderson, R. G. W. (1986) J. Cell Biol. 103, 2273-2281 [Abstract/Free Full Text]
  11. Hutton, J. C. (1982) Biochem. J. 204, 171-178 [Medline] [Order article via Infotrieve]
  12. Orci, L. (1985) Diabetologia 28, 528-546 [Medline] [Order article via Infotrieve]
  13. Coore, H. G., Hellman, B., Pihl, E., and Täljedal, I.-B. (1969) Biochem. J. 111, 107-113 [Medline] [Order article via Infotrieve]
  14. Berson, S. A., and Yalow, R. S. (1966) Am. J. Med. 40, 676-690 [CrossRef][Medline] [Order article via Infotrieve]
  15. Helmerhorst, E., and Stokes, G. B. (1986) Arch. Biochem. Biophys. 245, 238-247 [CrossRef][Medline] [Order article via Infotrieve]
  16. Chow, R. H., von Ruden, L., and Neher, E. (1992) Nature 356, 60-62 [CrossRef][Medline] [Order article via Infotrieve]
  17. Ciolkowski, E. L., Cooper, B. R., Jankowski, J. A., Jorgenson, J. W., and Wightman, R. M (1992) J. Am. Chem. Soc. 114, 2815-2821 [CrossRef]
  18. Leszczyszyn, D. J., Jankowski, J. A., Viveros, O. H., Diliberto, E. J., Jr., Near, J. A., and Wightman, R. M. (1990) J. Biol. Chem. 265, 14736-14737 [Abstract/Free Full Text]
  19. Wightman, R. M., Jankowski, J. A., Kennedy, R. T., Kawagoe, K. T., Schroeder, T. J., Leszczyszyn, D. J., Near, J. A., Diliberto, E. J., and Viveros, O. H. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 10754-10758 [Abstract/Free Full Text]
  20. Chen, T. K., Luo, G., and Ewing, A. G. (1994) Anal. Chem. 66, 3031-3035 [Medline] [Order article via Infotrieve]
  21. Alvarez de Toledo, G., Fernandez-Chacon, R., and Fernandez, J. M. (1993) Nature 363, 554-558 [CrossRef][Medline] [Order article via Infotrieve]
  22. Zhou, Z., and Misler, S. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 6938-6942 [Abstract/Free Full Text]
  23. Paras, C. D., and Kennedy, R. T. (1995) Anal. Chem. 67, 3633-3637 [Medline] [Order article via Infotrieve]
  24. Paras, C. D., and Kennedy, R. T. (1997) Electroanalysis 9, 203-208 [CrossRef]
  25. Jankowski, J. A., Schroeder, T. J., Ciolkowski, E. L., and Wightman, R. M. (1993) J. Biol. Chem. 268, 14694-14700 [Abstract/Free Full Text]
  26. Jankowski, J. A., Finnegan, J. M., and Wightman, R. M. (1994) J. Neurochem. 63, 1739-1747 [Medline] [Order article via Infotrieve]
  27. Borges, R., Travis, E. R., Hochstetler, S. E., and Wightman, R. M. (1997) J. Biol. Chem. 272, 8325-8331 [Abstract/Free Full Text]
  28. Walker, A., Glavinovic, M. I., and Trifaro, J.-M. (1996) Pfluegers Arch. Eur. J. Physiol. 431, 729-735 [Medline] [Order article via Infotrieve]
  29. Fernandez-Chacon, R., and de Toledo, G. A. (1995) FEBS Lett. 363, 221-225 [CrossRef][Medline] [Order article via Infotrieve]
  30. Oberhauser, A. F., Robinson, I. M., and Fernandez, J. M. (1996) Biophys. J. 71, 1131-1139 [Abstract/Free Full Text]
  31. Huang, L., Shen, H., Atkinson, M. A., and Kennedy, R. T. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 608-612
  32. Kennedy, R. T., Huang, L., Atkinson, M. A., and Dush, P. (1993) Anal. Chem. 65, 1882-1887 [Medline] [Order article via Infotrieve]
  33. Gazzano, H., Halban, P., Prentki, M., Ballotti, R., Brandenburg, D., Fehlmann, M., and Van Obberghen, E. (1985) Biochem. J. 226, 867-872 [Medline] [Order article via Infotrieve]
  34. Smith, P. A., Duchen, M. R., and Ashcroft, F. M. (1994) J. Physiol. 475P, 157P
  35. Smith, P. A., Duchen, M. R., and Ashcroft, F. M. (1995) Pfluegers Arch. Eur. J. Physiol. 430, 808-818 [CrossRef][Medline] [Order article via Infotrieve]
  36. Zhou, Z., and Misler, S. (1996) J. Biol. Chem. 271, 270-277 [Abstract/Free Full Text]
  37. Kennedy, R. T., Huang, L., and Aspinwall, C. A. (1996) J. Am. Chem. Soc. 118, 1795-1796 [CrossRef]
  38. Kawagoe, K. T., Zimmerman, J. B., and Wightman, R. M. (1993) J. Neurosci. Methods 48, 225-240 [CrossRef][Medline] [Order article via Infotrieve]
  39. Kelly, R. S., and Wightman, R. M. (1986) Anal. Chim. Acta 187, 79-87
  40. Ricordi, C., Lacy, P. E., Finke, E. H., Olack, B. J., and Scharp, D. W. (1988) Diabetes 37, 413-420 [Abstract]
  41. Warnock, G. L., Ao, Z., Lakey, J. R. T., and Rajotte, R. V. (1994) in Pancreatic Islet Transplantation Vol I: Procurement of Pancreatic Islets (Lanza, R. P., and Chick, W. L., eds), pp. 81-95, R. G. Landes, Austin, TX
  42. Barnett, D. W., Pressel, D. M., Chern, H. T., Scharp, D. W., and Misler, S. (1994) J. Membr. Biol. 138, 113-120 [Medline] [Order article via Infotrieve]
  43. Schroeder, T. J., Jankowski, J. A., Kawagoe, K. T., Wightman, R. M., Lefrou, C., and Amatore, C. (1992) Anal. Chem. 64, 3077-3083 [Medline] [Order article via Infotrieve]
  44. Bowman, E. J., Siebers, A., and Altendorf, K. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 7972-7976 [Abstract/Free Full Text]
  45. Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., and Tashiro, Y. (1991) J. Biol. Chem. 266, 17707-17712 [Abstract/Free Full Text]
  46. Pihel, K., Travis, E. R., Borges, R., and Wightman, R. M. (1996) Biophys. J. 71, 1633-1640 [Abstract/Free Full Text]
  47. Hurley, L. S. (1969) Am. J. Clin. Nutr. 22, 1332-1341 [Abstract]
  48. Chen, M.-D., Lin, P.-Y., Tsuo, C.-T., Wang, J.-J., and Lin, W.-H. (1995) Biol. Trace Element Res. 50, 119-124 [Medline] [Order article via Infotrieve]
  49. Zalewski, P. D., Forbes, I. J., and Betts, W. H. (1993) Biochem. J. 296, 403-408
  50. Bonner, F. W., King, L. J., and Parke, D. V. (1979) Chem. Biol. Interact. 27, 343-351 [CrossRef][Medline] [Order article via Infotrieve]
  51. Nanavati, C., and Fernandez, J. M. (1993) Science 259, 963-965 [Abstract]
  52. Rahamimoff, R., and Fernandez, J. M. (1997) Neuron 18, 17-27 [CrossRef][Medline] [Order article via Infotrieve]
  53. Wightman, R. M., Schroeder, T. J., Finnegan, J. M., Ciolkowski, E. L., and Pihel, K. (1995) Biophys. J. 68, 383-390 [Abstract/Free Full Text]
  54. Schroeder, T. J., Borges, R., Finnegan, J. M., Pihel, K., Amatore, C., and Wightman, R. M. (1996) Biophys. J. 70, 1061-1068 [Abstract/Free Full Text]
  55. Ehrhart, M., Grube, D., Bader, M. F., Aunis, D., and Gratzl, M. (1986) J. Histochem. Cytochem. 34, 1673-1682 [Abstract]
  56. Hutton, J. C., Peshavakia, M., Johnston, C. F., Ravazzola, M., and Orci, L. (1988) Endocrinology 122, 1014-1020 [Abstract]
  57. Guest, P. C., Rhodes, C. J., and Hutton, J. C. (1989) Biochem. J. 257, 431-437 [Medline] [Order article via Infotrieve]
  58. Hutton, J. C. (1989) Diabetologia 32, 271-281 [CrossRef][Medline] [Order article via Infotrieve]
  59. Patel, Y. C., Amherdt, M., and Orci, L. (1982) Science 217, 1155-1156 [Abstract/Free Full Text]
  60. Rothenberg, P. L., Willison, L. D., Simon, J., and Wolf, B. A. (1995) Diabetes 44, 802-809 [Abstract]
  61. Xu, G., Howland, J., and Rothenberg, P. L. (1996) Biochem. J. 318, 623-629
  62. Hazelwood, R. L. (1989) The Endocrine Pancreas, Prentice Hall, Englewood Cliffs, NJ

Volume 272, Number 50, Issue of December 12, 1997 pp. 31308-31314
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
PhysiologyHome page
P. E. MacDonald and P. Rorsman
The Ins and Outs of Secretion from Pancreatic {beta}-Cells: Control of Single-Vesicle Exo- and Endocytosis
Physiology, April 1, 2007; 22(2): 113 - 121.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Stiernet, Y. Guiot, P. Gilon, and J.-C. Henquin
Glucose Acutely Decreases pH of Secretory Granules in Mouse Pancreatic Islets: MECHANISMS AND INFLUENCE ON INSULIN SECRETION
J. Biol. Chem., August 4, 2006; 281(31): 22142 - 22151.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Brigadski, M. Hartmann, and V. Lessmann
Differential Vesicular Targeting and Time Course of Synaptic Secretion of the Mammalian Neurotrophins
J. Neurosci., August 17, 2005; 25(33): 7601 - 7614.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A.-L. Prost, A. Bloc, N. Hussy, R. Derand, and M. Vivaudou
Zinc is both an intracellular and extracellular regulator of KATP channel function
J. Physiol., August 15, 2004; 559(1): 157 - 167.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Eto, T. Yamashita, K. Hirose, Y. Tsubamoto, E. K. Ainscow, G. A. Rutter, S. Kimura, M. Noda, M. Iino, and T. Kadowaki
Glucose metabolism and glutamate analog acutely alkalinize pH of insulin secretory vesicles of pancreatic {beta}-cells
Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E262 - E271.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. S. Tompkins, K. D. Nullmeyer, S. M. Murphy, C. S. Weber, and R. M. Lynch
Regulation of secretory granule pH in insulin-secreting cells
Am J Physiol Cell Physiol, August 1, 2002; 283(2): C429 - C437.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Xu, J. Wu, N. Cui, L. Abdulkadir, R. Wang, J. Mao, L. R. Giwa, S. Chanchevalap, and C. Jiang
Distinct Histidine Residues Control the Acid-induced Activation and Inhibition of the Cloned KATP Channel
J. Biol. Chem., October 12, 2001; 276(42): 38690 - 38696.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. Williams and W. Webb
Single granule pH cycling in antigen-induced mast cell secretion
J. Cell Sci., January 11, 2000; 113(21): 3839 - 3850.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-N. Yang, O. Larsson, R. Branstrom, A. M. Bertorello, B. Leibiger, I. B. Leibiger, T. Moede, M. Kohler, B. Meister, and P.-O. Berggren
Syntaxin 1 interacts with the LD subtype of voltage-gated Ca2+ channels in pancreatic beta cells
PNAS, August 31, 1999; 96(18): 10164 - 10169.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Aspinwall, J. R. T. Lakey, and R. T. Kennedy
Insulin-stimulated Insulin Secretion in Single Pancreatic Beta Cells
J. Biol. Chem., March 5, 1999; 274(10): 6360 - 6365.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W. Han, D. Li, A. K. Stout, K. Takimoto, and E. S. Levitan
Ca2+-Induced Deprotonation of Peptide Hormones Inside Secretory Vesicles in Preparation for Release
J. Neurosci., February 1, 1999; 19(3): 900 - 905.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Xu, N. Cui, Z. Yang, J. Wu, L. R. Giwa, L. Abdulkadir, P. Sharma, and C. Jiang
Direct Activation of Cloned KATP Channels by Intracellular Acidosis
J. Biol. Chem., April 13, 2001; 276(16): 12898 - 12902.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. S. Zawalich, G. J. Tesz, and K. C. Zawalich
Are 5-Hydroxytryptamine-preloaded beta -Cells an Appropriate Physiologic Model System for Establishing That Insulin Stimulates Insulin Secretion?
J. Biol. Chem., September 28, 2001; 276(40): 37120 - 37123.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Aspinwall, W.-J. Qian, M. G. Roper, R. N. Kulkarni, C. R. Kahn, and R. T. Kennedy
Roles of Insulin Receptor Substrate-1, Phosphatidylinositol 3-Kinase, and Release of Intracellular Ca2+ Stores in Insulin-stimulated Insulin Secretion in beta -Cells
J. Biol. Chem., July 14, 2000; 275(29): 22331 - 22338.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract